ReviewNature reviews. Endocrinology2026
Risk factors, management and consequences of severe menopausal vasomotor symptoms.
Review in Nature reviews. Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Menopause in the spotlight: important research and clinical advances.Nature reviews. Endocrinology · 2026Article
- The moderating role of psychosocial work factors in the association between menopausal symptoms and work impairment.Scandinavian journal of work, environment & health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Menopause, particularly the consequences of severe symptoms, has become the subject of intense media interest. Reducing the prevalent stigma around women's reproductive health has allowed more women to speak openly about their menopause experiences, the effects on their lives and the barriers they face. These effects are far-reaching and illustrate the importance of improving the understanding, management and awareness of severe menopausal symptoms. The cardinal symptoms are hot flushes (or flashes) and night sweats (vasomotor symptoms), although symptoms can vary by ethnicity. For example, some Asian women report other primary symptoms (such as bone and/or joint pain). Vasomotor symptoms affect around 70% of perimenopausal and postmenopausal women and are moderate or severe in around one-third of these women. The US Food and Drug Administration considers vasomotor symptoms to be severe if they cause the person to stop their current activity. Severe vasomotor symptoms drive treatment seeking and can affect quality of life, mental health and work ability. We review the incidence, management and potential long-term health consequences of severe vasomotor symptoms, including cardiovascular disease, diabetes mellitus, cognitive dysfunction, bone health and quality of life. We discuss potential underlying mechanisms and the efficacy of available treatments. Finally, we highlight the evidence gaps in this field and directions for future research.
Indexed as
Identifiers
41882338What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.